2025 research hotspots and prospects of endocrine therapy for HR<sup>+</sup>/HER2<sup>-</sup> breast cancer
Hormone receptor-positive(HR<sup>+</sup>)/human epidermal growth factor receptor 2-negative (HER2<sup>-</sup>) breast cancer is the most common breast cancer subtype, with endocrine therapy as its core treatment modality. In recent years, the treatment paradigm has shifted toward a comprehensive man...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial Office of China Oncology
2026-02-01
|
| coleção: | Zhongguo aizheng zazhi |
| Assuntos: | |
| Acesso em linha: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2026.02.005 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|